Try our Advanced Search for more refined results

Expert Analysis

A Look At Middlemen Fees In 340B Drug Discount Program

By William Sarraille, Shanyue Zeng and Rory Martin ( December 3, 2025, 6:06 PM EST) -- On Oct. 23, the U.S Senate Committee on Health, Education, Labor and Pensions held a hearing on the 340B program, a controversial program that provides heavy discounts to qualifying providers that can then seek undiscounted reimbursements from most payors for those drugs.[1]...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies